Attenuation of corticotropin releasing factor-induced hypotension in anesthetized rats with the CRF antagonist, α-helical CRF9–41; Comparison with effect on ACTH release

[1]  A. F. Muller,et al.  Tumor necrosis factor alpha inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors. , 1990, Endocrinology.

[2]  F. Porreca,et al.  Gastrointestinal motor effects of corticotropin-releasing factor in mice , 1990, Regulatory Peptides.

[3]  M. Besser,et al.  Vasopressin Mediates α1-Adrenergic Stimulation of Adrenocorticotropin Secretion* , 1990 .

[4]  J. Kiang,et al.  Peptides of the corticoliberin superfamily attenuate thermal and neurogenic inflammation in rat pawskin. , 1989, European journal of pharmacology.

[5]  S. Gardiner,et al.  Regional haemodynamic effects of depressor neuropeptides in conscious, unrestrained, Long Evans and Brattleboro rats , 1988, British journal of pharmacology.

[6]  B. Waeber,et al.  Effect of Ganglion Blockade with Pentolinium on Circulating Neuropeptide Y Levels in Conscious Rats , 1988, Journal of cardiovascular pharmacology.

[7]  V. Castagné,et al.  Stress-induced changes of circulating neuropeptide Y in the rat: comparison with catecholamines , 1987, Regulatory Peptides.

[8]  J. M. Peterson,et al.  Corticotropin-releasing factor directly mediates colonic responses to stress. , 1987, The American journal of physiology.

[9]  D. Gann,et al.  Comparison of corticotropin-releasing factor and acetylcholine on catecholamine secretion in dogs. , 1987, The American journal of physiology.

[10]  H. Itoh,et al.  Differential antagonism of alpha-1 and alpha-2 adrenoceptor-mediated pressor responses by urotensin I, a selective mesenteric vasodilator peptide. , 1987, The Journal of pharmacology and experimental therapeutics.

[11]  H. Itoh,et al.  Relationship of urotensin I induced vasodilatory action in rat thoracic aorta to Ca2+ regulation. , 1987, Canadian journal of physiology and pharmacology.

[12]  T. Gray,et al.  Corticotropin-releasing factor receptor antagonist: effects on the autonomic nervous system and cardiovascular function , 1986, Regulatory Peptides.

[13]  G. Chrousos,et al.  Hemodynamic effects of corticotropin releasing hormone in the anesthetized cynomolgus monkey , 1986, Peptides.

[14]  G. Chrousos,et al.  Functional corticotropin releasing factor receptors in the primate peripheral sympathetic nervous system , 1986, Nature.

[15]  R. Corder,et al.  An immunoradiometric assay for the measurement of neuropeptide Y in plasma , 1985, Peptides.

[16]  G. Chrousos,et al.  Effects and pharmacokinetic properties of the rat/human corticotropin-releasing factor in rhesus monkeys. , 1985, Endocrinology.

[17]  W. Vale,et al.  Corticotropin-releasing factor, sauvagine, and urotensin I: effects on blood flow. , 1985, The American journal of physiology.

[18]  W. Vale,et al.  Synthetic competitive antagonists of corticotropin-releasing factor: effect on ACTH secretion in the rat. , 1984, Science.

[19]  B. Allolio,et al.  Development of a non-extracted 'two-site' immunoradiometric assay for corticotropin utilizing extreme amino- and carboxy-terminally directed antibodies. , 1984, The Biochemical journal.

[20]  W. Vale,et al.  Isolation, analysis of structure, synthesis, and biological actions of urotensin I neuropeptides. , 1983, Canadian journal of biochemistry and cell biology = Revue canadienne de biochimie et biologie cellulaire.

[21]  R. Guillemin,et al.  Culture of Enzymatically Dispersed Anterior Pituitary Cells: Functional Validation of a Method , 1972 .

[22]  A. Kenny,et al.  Metabolism of neuropeptides. Hydrolysis of the angiotensins, bradykinin, substance P and oxytocin by pig kidney microvillar membranes. , 1987, The Biochemical journal.